跳转至内容
Merck
CN

EMU064071

MISSION® esiRNA

targeting mouse Dpysl3

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

NACRES:
NA.51
UNSPSC Code:
41105324
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


description

Powered by Eupheria Biotech

Quality Level

product line

MISSION®

form

lyophilized powder

esiRNA cDNA target sequence

ATCAAGGGAGGGAGAATCGTCAATGATGATCAGTCCTTTTATGCTGATATTTACATGGAGGATGGCTTAATAAAGCAAATTGGAGACAATCTGATTGTCCCCGGAGGTGTGAAGACCATCGAGGCCAACGGGAAGATGGTGATCCCTGGAGGCATTGACGTCCATACCCACTTCCAGATGCCTTACAAGGGAATGACCACAGTGGACGATTTCTTCCAAGGGACAAAGGCTGCCTTAGCGGGAGGCACCACCATGATCATTGACCATGTGGTACCTGAACCTGAGTCTAGCCTGACAGAGGCCTATGAAAAGTGGCGTGAGTGGGCCGATGGGAAGAGCTGCTGTGACTATGCTTTGCATGTGGACATCACCCACTGGAATGACAGCGTCAAGCAGGAGGTACAGAGCC

Ensembl | mouse accession no.

NCBI accession no.

shipped in

ambient

storage temp.

−20°C

Gene Information

General description

MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.

For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.

Legal Information

MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany


存储类别

10 - Combustible liquids

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

新产品

此项目有



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



Ke Li et al.
Oncotarget, 6(12), 10030-10044 (2015-04-19)
Prostate cancer is the most commonly diagnosed non-cutaneous cancer and one of the leading causes of cancer death for North American men. Whereas localized prostate cancer can be cured, there is currently no cure for metastatic prostate cancer. Here we
Hisaharu Oya et al.
Journal of gastroenterology, 50(5), 590-600 (2014-09-01)
Patients with hepatocellular carcinoma (HCC) may relapse after curative resection. Sensitive biomarkers for HCC are required to enhance disease management. Dihydropyrimidinase-like 3 (DPYSL3) suppresses cell proliferation and tumorigenicity of certain malignancies; however, its role in HCC is unknown. The expression



全球贸易项目编号

货号GTIN
EMU064071-20UG04061828490974
EMU064071-50UG04061828265657